Filter
1725
Filtered Results: 1725
Text search:
National
Medicines
Regulatory
Authority
Featured
Recommendations
164
New Publications
481
Language
Document type
No document type
829
Studies & Reports
325
Guidelines
290
Manuals
119
Strategic & Response Plan
101
Fact sheets
25
Situation Updates
15
Training Material
12
Resource Platforms
4
Brochures
3
Infographics
1
Online Courses
1
Countries / Regions
Kenya
64
Global
63
India
59
Ethiopia
49
Uganda
37
Nigeria
35
South Africa
35
Liberia
34
Western and Central Europe
33
Tanzania
29
Ghana
28
Zambia
28
Sierra Leone
26
Ukraine
24
Nepal
23
Africa
23
Latin America and the Carribbean
22
South–East Asia Region
21
Bangladesh
21
Rwanda
20
Malawi
18
Eastern Europe
17
Myanmar / Burma
15
Syria
13
West and Central Africa
13
Namibia
13
Lesotho
12
Zimbabwe
12
Philippines
12
East and Southern Africa
11
Guinea
9
Eswatini/ Swaziland
9
Asia
8
Middle East and North Africa
8
Cambodia
7
Botswana
7
Congo, Democratic Republic of
6
Indonesia
6
Mozambique
5
USA
5
Eastern Europe and Central Asia
5
Sudan
5
Pakistan
5
Senegal
4
Jordan
4
Western Pacific Region
4
Moldova
4
Georgia
4
Somalia
4
Tajikistan
3
Thailand
3
Benin
3
Cameroon
3
Albania
3
Laos
3
Burkina Faso
3
Afghanistan
3
Haiti
3
Germany
3
North America
3
Iran
2
Peru
2
Turkmenistan
2
Bosnia and Herzegovina
2
Lebanon
2
Vietnam
2
Papua New Guinea
2
Russia
2
South Sudan
2
Ecuador
2
North Macedonia
1
Colombia
1
Timor Leste/ East Timor
1
Turkey
1
Australia
1
Kazakhstan
1
Chile
1
Fiji
1
Kyrgyzstan
1
Uzbekistan
1
Morocco
1
Qatar
1
Saudi Arabia
1
Paraguay
1
Gabon
1
Denmark
1
Maldives
1
Tunisia
1
United Kingdom
1
Belarus
1
Bolivia
1
Brazil
1
Sri Lanka
1
Egypt
1
Greece
1
Palestine
1
Mali
1
Chad
1
Libya
1
Iraq
1
Madagascar
1
Authors & Publishers
Publication Years
Category
Countries
648
Clinical Guidelines
145
Public Health
120
Women & Child Health
67
Key Resources
67
Pharmacy & Technologies
50
Capacity Building
10
Toolboxes
AMR
146
COVID-19
121
Pharmacy
120
HIV
119
TB
103
Mental Health
70
Rapid Response
63
Planetary Health
61
Caregiver
55
Global Health Education
37
Ebola & Marburg
36
NTDs
31
NCDs
29
Conflict
28
Disability
20
Specific Hazards
19
Refugee
16
Natural Hazards
15
Health Financing Toolbox
9
Zika
9
Polio
8
Cholera
4
Malaria
3
Social Ethics
2
Member States have requested WHO policy guidance on how to facilitate the implementation of national AMS activities in an integrated and programmatic approach. This policy guidance responds to that demand from Member States and is anchored in public health guiding principles in the human health sect...
Considerations for implementing and adjusting public health and social measures in the context of COVID-19
recommended
interim guidance, 14 June 2021
This document is intended for national authorities and decision makers in countries that have introduced large scale public health and social measures. It offers guidance for adjusting public health and social measures, while managing the risk of a resurgence of cases...
The report provides a brief introduction to patents and licences and their effect on the market for antiretroviral (ARV) medicines. It gives an overview of the patent landscape with respect to a select number of ARV medicines in developing countries as of April 2014. The focus is primarily on those ...
The project will support preventive actions, traditional medicine and the coordination and
implementation capacities of the national framework for HIV/AIDS control.
Guidelines for the registration of microbial, botanical and semiochemical pest control agents for plant protection and public health uses.
These guidelines are intended to guide pesticide regulatory authorities in the registration of microbial, botanical, and semiochemical pest control agents for p...
A survey was conducted in countries in all six WHO regions and focused on the building blocks that are considered prerequisites to combat antimicrobial resistance: a comprehensive national plan, laboratory capacity to undertake surveillance for resistant microorganisms, access to safe, effective ant...
This document is a guide defining requirements for quality and safety for malaria rapid diagnostic testing services to safeguard the quality of the results, the safety of the operators and patients and that of the environment for use by national malaria control programmes, regulators, implementers a...
Replacement of Annex 2 of WHO Technical Report Series, No. 964...
The document "Priority medical devices list for the COVID-19 response and associated technical specifications" complements this guideline.
This document provides interim guidance on the quality, performance characteristics and related standards of personal protective equipment (PPE) to be used i...
For thousands of years, humans have been using wildlife for commercial and subsistence purposes. Wildlife trade takes place at local, national and international levels, with different forms of wildlife, such as live animals, partly processed products and finished products. Wildlife is a vital source...
Overcoming barriers in low- and middle-income countries
For the first time, this year’s report includes information on hepatitis C diagnostics. With a focus on selected countries with diverse HCV epidemics, the report provides updates on the various dimensions of access to HCV diagnostics and pha...
Operational guide: use of referral laboratories for the analysis of foodborne hazards in the Pacific
The Operational guide: use of referral laboratories for the analysis of foodborne hazards in the Pacific aims to strengthen the food analysis capacity of Pacific Island countries and areas by identifying national and reference laboratories capable of testing for priority foodborne hazards. The Pacif...
Despite the considerable improvement in global health, millions of people still lack access to quality health services, including access to effective antimicrobial medicines, or are impoverished as a result of health spending. At the same time, antimicrobial resistance – a consequence of overuse a...
Cryptococcal disease is one of the most common opportunistic infections among people living with advanced HIV disease and is a major contributor to severe illness, morbidity, and mortality, particularly in sub-Saharan Africa.
These guidelines update the recommendations that were first released i...
Contact tracing and quarantine in the context of COVID-19: interim guidance, 6 July 2022
recommended
Contact tracing for COVID-19 is the process of identifying, assessing, and managing people who have been exposed to someone who has been infected with the SARS-CoV-2 virus, while quarantine is the separation of contacts from other people after exposure to a probable or confirmed case of SARS-CoV-2 i...
Policy brief, 24 July 2020
The COVID-19 pandemic has affected older people disproportionately, especially those living in long-term care facilities. In many countries, evidence shows that more than 40% of COVID-19 related deaths have been linked to long-term care facilities, with figures being as h...
The protracted humanitarian situation in northeastern Nigeria, particularly in Borno, Adamawa, and Yobe (BAY) States, remains a concern due to ongoing insecurity, displacement, food insecurity, disease outbreaks, and climate-related shocks. To address these complex challenges, the health sector has ...
April 2022 Volume 35 Issue 2 e00152-21
Population movements have turned Chagas disease (CD) into a global public health problem. Despite the successful implementation of subregional initiatives to control vectorial and transfusional Trypanosoma cruzi transmission in Latin American settings where t...
The purpose of these guidelines is to help health workers to participate in the process of continuous surveillance of safety and efficacy of the pharmaceutical products which are used in clinical practice, thus help to achieve the ultimate goal to make safer and more effective treatment available to...
